- Billionaire activist Carl Icahn is preparing a proxy fight at Illumina Inc ILMN, saying the company went ahead with the controversial acquisition of Grail Inc despite opposition from regulators, costing shareholders $50 billion.
- According to the letter viewed by Wall Street Journal, the activist plans to nominate three people to the company's board.
- Mr. Icahn accuses Illumina of overpaying for a business that made "exactly zero dollars in revenue," then closing the deal despite regulatory hiccups.
- Related: European Commission Says No To Illumina-Grail Deal - What's Next?
- He writes that holding on to Grail is costing Illumina $800 million annually, and that it faces a significant tax bill if ultimately forced to divest it.
- Illumina was valued at over $70 billion in 2021, but currently, the company has lost over 50% of its value to around $30 billion as the Grail deal remains in limbo while the company faces heightened competition from lower-cost rivals.
- Also Read: Illumina Shares Tank After Annual Guidance Fall Short Of Expectations.
- "We are convinced that at least three shareholder representatives are needed on Illumina's board to attempt to end this insanity now before the reckless decision-making escalates into a no-return situation," Mr. Icahn writes in the letter.
- Illumina said it recommends its shareholders vote against Mr. Icahn's nominees.
- "Illumina has a diverse, experienced board comprised of directors who bring a range of perspectives to the company and represent the interests of its stockholders," the company said.
- Price Action: ILMN shares are up 8.53% at $210.55 during the premarket session on the last check Monday.
Loading...
Loading...
ILMNIllumina Inc
$80.525.46%
Edge Rankings
Momentum
12.15
Growth
7.82
Quality
-
Value
47.23
Price Trend
Short
Medium
Long
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
